HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HER2 mRNA status contributes to the discrepancy between gene amplification and protein overexpression in gastric cancer.

AbstractBACKGROUND:
Human epidermal growth factor receptor 2 (HER2) is an important proto-oncogene of prognostic use in gastric cancer (GC). Fluorescence in-situ hybridization (FISH) and immunohistochemistry (IHC) are the main clinical methods of detection of HER2, but consistency between the methods is poor and the cause of the discrepancy is unclear.
AIM:
To investigate the involvement of HER2 mRNA status in the disparity between gene amplification and protein overexpression.
METHODS:
We investigated HER2 gene, mRNA, and protein profiles in gastric precancer and cancer tissues by use of the molecular approaches FISH, real-time polymerase chain reaction, and IHC. The relationships between HER2 and matrix metalloproteinase 9 (MMP9) and Smad7 expression were analyzed and the involvement of HER2 in the interaction between tumor cells and lymphocytes was investigated by coculturing GC cell lines with peripheral blood mononuclear cells (PBMCs).
RESULTS:
HER2 protein expression was significantly increased in cancer compared with precancer (P = 0.003), and the corresponding mRNA levels were significantly lower in precancer and cancer tissues than in normal tissues (κ = 0.290, P = 0.025). HER2 mRNA levels were significantly higher in tumor than in peritumor tissue (P = 0.028), and were positively correlated with MMP9 and Smad7 mRNA levels in tumor tissues. HER2 mRNA expression in GC cell lines was increased by coculture with PBMCs.
CONCLUSIONS:
Different HER2 mRNA profiles, possibly in relation to contact between tumor cells and lymphocytes, might help to explain the discrepancy between gene amplification and protein overexpression results.
AuthorsGui-Fen Ma, Yi-Mei Liu, Hong Gao, Qing Miao, Tian-Cheng Luo, Xiao-Qing Zeng, Shi-Yao Chen
JournalDigestive diseases and sciences (Dig Dis Sci) Vol. 59 Issue 2 Pg. 328-35 (Feb 2014) ISSN: 1573-2568 [Electronic] United States
PMID24185685 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
  • MAS1 protein, human
  • Proto-Oncogene Mas
  • RNA, Messenger
  • SMAD7 protein, human
  • Smad7 Protein
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • MMP9 protein, human
  • Matrix Metalloproteinase 9
Topics
  • Adult
  • Aged
  • Biomarkers, Tumor (genetics, metabolism)
  • Case-Control Studies
  • Cell Line, Tumor
  • Coculture Techniques
  • Female
  • Gene Amplification
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization, Fluorescence
  • Leukocytes, Mononuclear (metabolism)
  • Male
  • Matrix Metalloproteinase 9 (genetics)
  • Middle Aged
  • Predictive Value of Tests
  • Proto-Oncogene Mas
  • RNA, Messenger (metabolism)
  • Real-Time Polymerase Chain Reaction
  • Receptor, ErbB-2 (genetics, metabolism)
  • Smad7 Protein (genetics)
  • Stomach Neoplasms (enzymology, genetics)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: